These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 33219675)

  • 21. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
    Nina PB; Dash AP
    Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.
    Polo R; García-Albéniz X; Terán C; Morales M; Rial-Crestelo D; Garcinuño MA; García Del Toro M; Hita C; Gómez-Sirvent JL; Buzón L; Díaz de Santiago A; Arellano JP; Sanz J; Bachiller P; Alfaro EM; Díaz-Brito V; Masiá M; Hernández-Torres A; Guerra JM; Santos J; Arazo P; Muñoz L; Arribas JR; Martínez de Salazar P; Moreno S; Hernán MA; Del Amo J;
    Clin Microbiol Infect; 2023 Jan; 29(1):85-93. PubMed ID: 35940567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism.
    Perrella A; Orlando V; Trama U; Bernardi FF; Menditto E; Coscioni E
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and frequency of COVID-19 among healthcare workers at a tertiary care centre in India: a case-control study.
    Dev N; Meena RC; Gupta DK; Gupta N; Sankar J
    Trans R Soc Trop Med Hyg; 2021 May; 115(5):551-556. PubMed ID: 33763687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina.
    Chahla RE; Medina Ruiz L; Ortega ES; Morales Rn MF; Barreiro F; George A; Mancilla Rn C; D' Amato Rn S; Barrenechea G; Goroso DG; Peral de Bruno M
    Am J Ther; 2021 Aug; 28(5):e601-e604. PubMed ID: 34491960
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.
    Lother SA; Abassi M; Agostinis A; Bangdiwala AS; Cheng MP; Drobot G; Engen N; Hullsiek KH; Kelly LE; Lee TC; Lofgren SM; MacKenzie LJ; Marten N; McDonald EG; Okafor EC; Pastick KA; Pullen MF; Rajasingham R; Schwartz I; Skipper CP; Turgeon AF; Zarychanski R; Boulware DR
    Can J Anaesth; 2020 Sep; 67(9):1201-1211. PubMed ID: 32383125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern.
    Nagaraja BS; Ramesh KN; Dhar D; Mondal MS; Dey T; Saha S; Khan MA; Rutul SD; Pratik K; Manjula J; Sangeeth TA; Singh V
    J Public Health (Oxf); 2020 Aug; 42(3):493-503. PubMed ID: 32490532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea.
    Bae S; Ghang B; Kim YJ; Lim JS; Yun SC; Kim YG; Lee SO; Kim SH
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.
    Lewis K; Chaudhuri D; Alshamsi F; Carayannopoulos L; Dearness K; Chagla Z; Alhazzani W;
    PLoS One; 2021; 16(1):e0244778. PubMed ID: 33406138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trust in the Time of COVID-19.
    Kittleson MM
    Am J Med; 2020 Dec; 133(12):1370-1371. PubMed ID: 32791058
    [No Abstract]   [Full Text] [Related]  

  • 31. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Big studies dim hopes for hydroxychloroquine.
    Kupferschmidt K
    Science; 2020 Jun; 368(6496):1166-1167. PubMed ID: 32527806
    [No Abstract]   [Full Text] [Related]  

  • 33. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19.
    Hennekens CH; Rane M; Solano J; Alter S; Johnson H; Krishnaswamy S; Shih R; Maki D; DeMets DL
    Am J Med; 2022 Jan; 135(1):7-9. PubMed ID: 34437834
    [No Abstract]   [Full Text] [Related]  

  • 36. Is Ocular Toxicity Expected in Chloroquine/Hydroxychloroquine Prescription as a Therapeutic or Prophylactic Option in COVID-19?
    Bagheri M; Rashe Z; Ahur MH; Eidizadeh M
    Recent Pat Antiinfect Drug Discov; 2020; 15(2):113-118. PubMed ID: 32814539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.
    Chatterjee P; Anand T; Singh KJ; Rasaily R; Singh R; Das S; Singh H; Praharaj I; Gangakhedkar RR; Bhargava B; Panda S
    Indian J Med Res; 2020 May; 151(5):459-467. PubMed ID: 32611916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study.
    Behera P; Patro BK; Singh AK; Chandanshive PD; S R R; Pradhan SK; Pentapati SSK; Batmanabane G; Mohapatra PR; Padhy BM; Bal SK; Singh SR; Mohanty RR
    PLoS One; 2021; 16(2):e0247163. PubMed ID: 33592050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can prophylactic drugs keep fragile health systems running?
    Kupferschmidt K
    Science; 2020 Apr; 368(6487):118-119. PubMed ID: 32273446
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials.
    Hong H; Friedland A; Hu M; Anstrom KJ; Halabi S; McKinnon JE; Amaravadi R; Rojas-Serrano J; Abella BS; Portillo-Vázquez AM; Woods CW; Hernandez AF; Boulware DR; Naggie S; Rajasingham R
    BMJ Open; 2023 Jun; 13(6):e065305. PubMed ID: 37328184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.